| Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients D Lacedonia, G Scioscia, C Santomasi, P Fuso, GE Carpagnano, ... Scientific Reports 11 (1), 19251, 2021 | 44 | 2021 |
| Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure A Portacci, F Diaferia, C Santomasi, S Dragonieri, E Boniello, F Di Serio, ... Respiratory medicine 187, 106556, 2021 | 40 | 2021 |
| The right interface for the right patient in noninvasive ventilation: A systematic review P Pierucci, A Portacci, GE Carpagnano, P Banfi, C Crimi, G Misseri, ... Expert Review of Respiratory Medicine 16 (8), 931-944, 2022 | 20 | 2022 |
| Prolonged active prone positioning in spontaneously breathing non-intubated patients with COVID-19-associated hypoxemic acute respiratory failure with PaO2/FiO2> 150 P Pierucci, N Ambrosino, V Di Lecce, M Dimitri, S Battaglia, E Boniello, ... Frontiers in medicine 8, 626321, 2021 | 20 | 2021 |
| Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps C Pelaia, A Benfante, MT Busceti, MF Caiaffa, R Campisi, ... Frontiers in Immunology 14, 1121237, 2023 | 19 | 2023 |
| Super-Responders to Biologic Treatment in Type 2–High Severe Asthma: Passing Fad or a Meaningful Phenotype? A Portacci, S Dragonieri, GE Carpagnano The Journal of Allergy and Clinical Immunology: In Practice 11 (5), 1417-1420, 2023 | 15 | 2023 |
| COVID-19 clinical phenotypes and short-term outcomes: Differences between the first and the second wave of pandemic in Italy A Portacci, GE Carpagnano, MG Tummolo, C Santomasi, L Palma, ... Expert Review of Respiratory Medicine 15 (12), 1619-1625, 2021 | 15 | 2021 |
| Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience A Portacci, I Iorillo, VN Quaranta, L Maselli, E Lulaj, E Buonamico, ... Respiratory Medicine 217, 107348, 2023 | 10 | 2023 |
| Benralizumab effectiveness in severe eosinophilic asthma with co-presence of bronchiectasis: a real-world multicentre observational study R Campisi, S Nolasco, C Pelaia, P Impellizzeri, M D’Amato, A Portacci, ... Journal of Clinical Medicine 12 (12), 3953, 2023 | 9 | 2023 |
| Switching biological therapies in severe asthma G Scioscia, S Nolasco, R Campisi, CMI Quarato, C Caruso, C Pelaia, ... International Journal of Molecular Sciences 24 (11), 9563, 2023 | 9 | 2023 |
| Patient's treatment burden related to care coordination in the field of respiratory diseases P Pierucci, C Santomasi, N Ambrosino, A Portacci, F Diaferia, K Hansen, ... Breathe 17 (1), 2021 | 9 | 2021 |
| Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study S Nolasco, A Portacci, R Campisi, E Buonamico, C Pelaia, A Benfante, ... Frontiers in Immunology 14, 1204444, 2023 | 8 | 2023 |
| Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis A Portacci, R Campisi, E Buonamico, S Nolasco, C Pelaia, N Crimi, ... ERJ Open Research 9 (5), 2023 | 5 | 2023 |
| Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A real-life study C Santomasi, E Buonamico, S Dragonieri, L Iannuzzi, A Portacci, ... Acta Bio Medica: Atenei Parmensis 94 (1), 2023 | 5 | 2023 |
| The predictors of long COVID in southeastern Italy VN Quaranta, A Portacci, S Dragonieri, C Locorotondo, E Buonamico, ... Journal of Clinical Medicine 12 (19), 6303, 2023 | 4 | 2023 |
| A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation A Portacci, P Pierucci, VN Quaranta, S Quaranta, I Iorillo, C Locorotondo, ... Expert Review of Respiratory Medicine 16 (10), 1093-1099, 2022 | 3 | 2022 |
| Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission GE Carpagnano, A Portacci, S Nolasco, A Detoraki, A Vatrella, ... Frontiers in Immunology 15, 1343362, 2024 | 2 | 2024 |
| Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose S Dragonieri, VN Quaranta, A Portacci, M Ahroud, M Di Marco, T Ranieri, ... Molecules 28 (15), 5755, 2023 | 2 | 2023 |
| Moderate to severe Vitamin D deficiency increases the risk for COVID-19 mortality in patients treated in a respiratory intensive care unit P Pierucci, VN Quaranta, S Dragonieri, A Portacci, MG Tummolo, ... Pol Arch Intern Med 131, 16119, 2021 | 2 | 2021 |
| Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development? A Portacci, M Amendolara, VN Quaranta, I Iorillo, E Buonamico, F Diaferia, ... Respiratory Medicine, 107628, 2024 | 1 | 2024 |
